medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2021, Number 05

<< Back Next >>

Ginecol Obstet Mex 2021; 89 (05)

Acute fatty liver of pregnancy: A postpartum onset case

Cebolla-Gil P, Villalobos-Salguero FJ, Díaz-Rabasa MB, Herrero-Serrano R, Ortega-Marcilla S, Rodríguez-Solanilla B

Language: Spanish
References: 15
Page: 415-419
PDF size: 152.84 Kb.


ABSTRACT

Background: Acute fatty liver disease of pregnancy is a rare, life-threatening, pregnancy-specific disease of unknown cause. It presents with hepatic microsteatosis, typically manifests in the third trimester of pregnancy and is reversible postpartum. The clinical presentation is usually nonspecific, with digestive prodromes.
Clinical case: 36-year-old female patient who, after a 37th week delivery, started with febrile peaks, progressively elevated transaminase values, alterations in glycemia and coagulation, leukocytosis and hyperbilirubinemia. It was necessary to admit her to the intensive care unit. Given the persistence of the condition, the need for a liver transplant was considered, but finally it was not necessarily due to the progressive improvement secondary to antibiotic support treatment, fresh plasma transfusion, fibrinogen and vitamin K administration. The differential diagnosis was established with preeclampsia and HELLP syndrome; in the end the diagnosis of acute fatty liver of pregnancy was established.
Conclusions: The clinical manifestation of acute fatty liver of pregnancy is highly variable and nonspecific; onset in the immediate postpartum period is possible. Multidisciplinary medical care and supportive treatment are decisive in the favorable evolution.


REFERENCES

  1. Sepúlveda-Martínez A, Romero C, Juárez G, Hasbun J, Parra-Cordero M. Actualización en el diagnóstico y manejo del daño hepático agudo grave en el embarazo. Rev Med Chil 2015; 143 (5): 627-36. doi. 10.4067/S0034- 98872015000500011.

  2. Liu J, Ghaziani TT, Wolf JL. Acute fattu liver disease of pregnancy: Updates in pathogenesis, diagnosis and management. Am J Gastroenterol 2017; 112 (6): 838-46. doi. 10.1038/ajg.2017.54.

  3. Ferrero A, Lorenzo E, Fernández-Corona A, Muñoz F, Hernández JL. Hígado graso agudo del embarazo: un diagnóstico inusual en obstetricia. Clin Invest Gin Obst. 2005; 32 (1): 27-9. https://doi.org/10.1016/S0210-573X(05)73469-9

  4. Allen AM, Kim WR, Larson JJ, Rosedahl JK, Yawn BP, McKeon K, Hay JE. The epidemiology of liver diseases unique to pregnancy in a us community: a population-based study. Clin Gastroenterol Hepatol. 2016; 14 (2): 287-94.e1-2. doi. 10.1016/j.cgh.2015.08.022.

  5. Sheehan HL. Jaundice in pregnancy. Am J Obstet Gynecol 1961; 81: 427-40. https://www.ajog.org/article/S0002- 9378(15)33659-0/abstract.

  6. Pockros PJ, Peters RL, Reynolds TB. Idiopathic fatty liver of pregnancy: findings in ten cases. Medicine (Baltimore) 1984; 63 (1): 1-11. doi. 10.1097/00005792-198401000- 00001.

  7. Schoeman MN, Batey RG, Wilcken B. Recurrent acute fatty liver of pregnancy associated with a fatty acid oxidation defect in the offspring. Gastroenterology 1991; 100 (2): 544-8. doi. 10.1016/0016-5085(91)90228-d.

  8. Browning MF, Levy HL, Wilkins-Haug LE, et al. Fetal fatty acid oxidation defects and maternal liver disease in pregnancy. Obstet Gynecol 2006; 107 (1): 115-20. doi. 10.1097/01.AOG.0000191297.47183.bd.

  9. Lamireau D1, Feghali H, Redonnet-Vernhet I, Mesli S, Carles D, Brissaud O. Acute fatty liver in pregnancy: revealing fetal fatty acid oxidation disorders. Arch Pediatr. 2012; 19 (3): 277-81. doi. 10.1016/j.arcped.2011.12.020.

  10. Spiekerkoetter U, Wood PA. Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse models. J Inherit Metab Dis. 2010; 33 (5): 539-46. doi. 10.1007/s10545-010-9121-7.

  11. Wei Q, Zhang L, Liu X. Clinical diagnosis and treatment of acute fatty liver of pregnancy: a literature review and 11 new cases. J Obstet Gynaecol Res 2010; 36 (4): 751-6. doi. 10.1111/j.1447-0756.2010.01242.x.

  12. Al-Husban N, Al-Kuran O, Al Helou A. Postpartum acute fatty liver of pregnancy: a case report. Journal of Medical Case Reports 2018; 12: 67. doi. 10.1186/s13256-018- 1593-3.

  13. Ch'ng CL, Morgan M, Hainsworth I, Kingham JGC. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002; 51 (6): 876-80. doi. 10.1136/gut.51.6.876.

  14. Morton A, Laurie J. Physiological changes of pregnancy and the Swansea criteria in diagnosing acute fatty liver of pregnancy. Obstet Med. 2018; 11 (3): 126-31. doi. 10.1177/1753495X18759353.

  15. Wang S, Li SL, Cao YX, Li YP, Meng JL, Wang XT. Noninvasive Swansea criteria are valuable alternatives for diagnosing acute fatty liver of pregnancy in a Chinese population. J Matern Fetal Neonatal Med 2017; 30 (24): 2951-55. doi. 10.1080/14767058.2016.1269316.




2020     |     www.medigraphic.com